Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

Alkyl Substitution Strategy for Tuning Mechanical Deformability and Photomechanical Behavior in Organic Crystals by Jiang Peng (474699)

S4 File - by Alireza Kooshki (20396328)

“…<div><p>The role of trace elements and toxic metals on human health has been extensively discussed concerning disease pathogenesis and risk factors of diseases. …”

S3 File - by Alireza Kooshki (20396328)

“…<div><p>The role of trace elements and toxic metals on human health has been extensively discussed concerning disease pathogenesis and risk factors of diseases. …”

Poor association between IgM-NS1 antibodies and CZS-related microcephaly. by Sebastián Castro-Trujillo (20513837)

Data Sheet 1_Post-translational modifications of beta-amyloid modulate its effect on cell mechanical properties and influence cytoskeletal signaling cascades.pdf by Kseniya B. Varshavskaya (18116647)

“…<p>Post-translational modifications of beta-amyloid (Aβ) play an important role in the pathogenesis of Alzheimer’s disease (AD). Aβ modifications such as Ser8 phosphorylation (pS8-Aβ₄₂) and Asp7 isomerization (iso-Aβ₄₂) can significantly alter the properties of Aβ and have been detected in vivo. …”

Data Sheet 3_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Data Sheet 4_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Table 4_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Data Sheet 1_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Table 2_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Data Sheet 2_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Table 3_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”